GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

On election day, Tuesday, November 5, Americans will choose between former President Donald Trump and current Vice President ...

Biopharma leaders at companies developing blood cancer therapies say we shouldn’t be afraid to use the four-letter word: cure ...

Morgan Stanley has chosen Eli Lilly (NYSE:LLY) as its top biopharma pick for 2025 and rated another nine names in the space ...

Morgan Stanley lowered the firm’s price target on Zenas BioPharma (ZBIO) to $35 from $40 and keeps an Overweight rating on the shares. The firm ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Buy rating on Zenas BioPharma, Inc. (ZBIO – Research Report), with ...

With the China-targeting Biosecure Act absent from a key defense spending bill revealed over the weekend, it appears the ...

President-elect Donald Trump and his incoming administration are unlikely to attempt a wholesale restructuring of U.S.

Vor Biopharma Inc (VOR) stock saw a modest uptick, ending the day at $1.04 which represents a slight increase of $0.22 or 26.83% from the prior close of $0.82. The stock opened at $0.86 and touched a ...

Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...

A Triangle pharmaceutical firm is expanding its portfolio as its parent company completes a $500 million deal.